Study of the Pharmacokinetics and Safety of Tasimelteon in Children and Adolescents

Clinical trial NCT02776215 · COMPLETED

Trial details

NCT number: NCT02776215
Sponsor: Vanda Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Circadian Rhythm Sleep Disorders Non-24 Hour Sleep-Wake Disorder Autism Spectrum Disorder Smith-Magenis Syndrome

Start date: 2016-10-04
Primary completion: 2017-12-20
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.